Abstract 1222A: Identification and targeting of CD34+CD176+IL1RAP+ chronic myeloid leukemia stem cells with bi-specific antibodies
Abstract Leukemia Stem Cells (LSCs) quiescence in Chronic Myeloid Leukemia (CML) plays a major role in therapeutic resistance and disease progression calling for the need for identifying and targeting such cells (1). LSCs belong to the primitive population; CD34+CD38-Lin-, which can’t distinguish no...
Saved in:
Published in | Cancer research (Chicago, Ill.) Vol. 79; no. 13_Supplement; pp. 1222 - 1222A |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
01.07.2019
|
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!